Industry Verticals »

All Categories

Insights »

About TMR »

Periodontal Therapeutics Market

Periodontal Therapeutics Market (Product Type - Systemic Antibiotics (Doxycycline, Minocycline, Metronidazole), Local Antibiotics (Arestin, Atridox, PerioChip); Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Stores, E-commerce - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global periodontal therapeutics market for the historical period 2017–2018 and forecast period 2019–2027, rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health are projected to drive the global periodontal therapeutics market
  • According to the report, the global periodontal therapeutics market was valued at US$ 536.8 Mn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2027
fa global periodontal therapeutics market
 

Rise in Global Burden of Periodontal Diseases: A Key Driver

  • Periodontal diseases comprising gingivitis and periodontitis are prevalent both in developing and developed countries and affect around 20% to 50% of the global population
  • According to the Global Burden of Disease Study (GBD, 1990–2010), severe periodontitis is the 6th most prevalent disease worldwide, and has an overall prevalence of 11.2% and an estimated 743 million people worldwide are affected by it. The global burden of periodontal diseases has increased by as much as 57.3% from 1990 to 2010.
  • Periodontitis is one of the major causes of tooth loss in adult population across the world. These individuals are at risk of edentulism, masticatory dysfunction, and multiple tooth loss which in turn affects nutrition, self-esteem, and quality of life as well as imposes high health care and significant socio-economic costs.
  • The global cost of lost productivity due to severe periodontitis is estimated to be around US$ 54 Bn per year, while the total economic impact of periodontal diseases accounts for a major component of the US$ 442 Bn direct and indirect cost caused due to oral diseases.

Surge in Awareness About Oral Health to Augment Global Market

  • Oral health programs work for formulation of national and community policies on effective control of diet and nutrition risk factors for oral diseases such as periodontal disease, dental disease, etc.
  • Periodontal diseases have a significant socio-economic impact on populations and governments across the world; however, treatment to these diseases still remains unavailable in developing countries due to low priority accorded to these diseases
  • The Global Periodontal Health Project (GPHP) was launched in October 2015 in order to reduce the overall global burden of periodontal diseases. The project aims to decrease the burden associated with these diseases by raising awareness of its impact and engaging oral health and other health professionals, policymakers, educators, and the general public in promoting periodontal health.
  • The Global Periodontal Health Project aims to make periodontal health a priority issue at the national level by engaging with Ministers of Health, Chief Dental Officers and the local populations, and also increase the disease awareness levels by actively disseminating dental educational promotional tools.

Uninsured Dental Care in Several Developed and Developing Countries to Hamper Global Periodontal Therapeutics Market

  • Advanced dental and periodontal procedures turn out to be too expensive for an average citizen in both developed and developing countries
  • Oral health care coverage is seen to be low in low- and middle-income countries. Dental care is not insured in several developed countries such as Canada and the U.S. In the U.S., only the most rudimentary dental care is covered by health insurance plan. According to the National Association of Dental Plans, over 114 million people in the U.S. were known to be without dental coverage in 2014.

North America to Account for Major Share of Global Periodontal Therapeutics Market

  • North America is projected to account for leading share of the global periodontal therapeutics market due to rise in product approvals, well-established health care infrastructure, increase in technological advancements, rise in number of well-equipped laboratories, surge in research & developmental activities in periodontal therapeutics, and presence of key players
  • The periodontal therapeutics market in Asia Pacific is projected to grow at a rapid pace during the forecast period due to increase in geriatric population, rise in research & developmental activities, surge in initiatives by governments in the health care sector, and rise in interest of key players in expanding presence in the region

Global Periodontal Therapeutics Market: Competitive Landscape

  • This report profiles major players in the global periodontal therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Key players operating in the global periodontal therapeutics market include
    • Den-Mat Holdings, LLC
    • Valeant Pharmaceuticals International, Inc.
    • Dexcel Pharma
    • 3M Company
    • Oral Science
    • Kaken Pharmaceutical Co., Ltd.

Global Periodontal Therapeutics Market: Key Developments

Key players in the global periodontal therapeutics market have adopted strategies such as regulatory approvals, advanced product development, launch of new products, increase in investments and funds, and acquisition & collaborative agreements with other companies. These strategies of key players are likely to fuel the growth of the global periodontal therapeutics market. Recent developments in line with these strategies by players operating in the global periodontal therapeutics market are:

  • In February 2017, Oral Science announced its decision to launch Fluorimax, a next-generation of fluoride varnishes intended to be used for the treatment of dental caries
  • In November 2016, Kaken Pharmaceutical Co., Ltd. announced that the company’s REGROTH Dental Kit, a medicinal product used for periodontal regeneration was listed on Japan’s National Health Insurance (NHI) drug reimbursement price list

The report on the global periodontal therapeutics market discusses individual strategies followed by company profiles of manufacturers of periodontal therapeutics treatment products. The competitive landscape section has been included in the periodontal therapeutics market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global periodontal therapeutics market.

Frequently Asked Questions

What is the total market worth of periodontal therapeutics market?

Periodontal therapeutics market is expected to reach US$ 1.1 billion by 2027

What is the anticipated CAGR of the periodontal therapeutics market in the forecast period?

Periodontal therapeutics market is anticipated to expand at a CAGR of 8.8% to 2019 to 2027

What are the key driving factors for the growth of the periodontal therapeutics market?

Periodontal therapeutics market is driven by rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health

Which is the rising prominent segment in the periodontal therapeutics market?

Local Antibiotics Segment to Account for Significant Share of Periodontal Therapeutics Market

Who are the key players in the global periodontal therapeutics market?

Top key players in periodontal therapeutics market are Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma, 3M Company, Oral Science, and Kaken Pharmaceutical Co., Ltd

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Periodontal Therapeutics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Periodontal Therapeutics Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Market Outlook

    5.1. Pricing Analysis

    5.2. Pipeline Analysis

    5.3. Re-imbursement Scenario

6. Global Periodontal Therapeutics Market Analysis and Forecast, by Product 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2027

        6.3.1. Systemic Antibiotics

            6.3.1.1. Doxycycline

            6.3.1.2. Minocycline

            6.3.1.3. Metronidazole

            6.3.1.4. Others

        6.3.2. Local Antibiotics

            6.3.2.1. Arestin

            6.3.2.2. Periochip

            6.3.2.3. Atridox

            6.3.2.4. Others

    6.4. Market Attractiveness, by Product 

7. Global Periodontal Therapeutics Market Analysis and Forecast, by Distribution Channel 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Distribution Channel, 2017–2027

        7.3.1. Hospitals Pharmacies

        7.3.2.  Retail Pharmacies

        7.3.3. Drug Stores

        7.3.4. E-Commerce

    7.4. Market Attractiveness Analysis, by Distribution Channel 

8. Global Periodontal Therapeutics Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Market Attractiveness Analysis, by Region

9. North America Periodontal Therapeutics Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast By Product, 2017–2027

        9.2.1. Systemic Antibiotics

            9.2.1.1. Doxycycline

            9.2.1.2. Minocycline

            9.2.1.3. Metronidazole

            9.2.1.4. Metronidazole

            9.2.1.5. Others

        9.2.2. Local Antibiotics

            9.2.2.1. Arestin

            9.2.2.2. Periochip

            9.2.2.3. Atridox

            9.2.2.4. Others

    9.3. Market Value Forecast, by Distribution Channel, 2017–2027

        9.3.1. Hospitals Pharmacies

        9.3.2.  Retail Pharmacies

        9.3.3. Drug Stores

        9.3.4. E-Commerce

    9.4. Market Value Forecast, by Country, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis 

        9.5.1. By Product 

        9.5.2. By Distribution Channel 

        9.5.3. By Country

10. Europe Periodontal Therapeutics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2027

        10.2.1. Systemic Antibiotics

            10.2.1.1. Doxycycline

            10.2.1.2. Minocycline

            10.2.1.3. Metronidazole

            10.2.1.4. Others

        10.2.2. Local Antibiotics

            10.2.2.1. Arestin

            10.2.2.2. Periochip

            10.2.2.3. Atridox

            10.2.2.4. Others

    10.3. Market Value Forecast, by Distribution Channel, 2017–2027

        10.3.1. Hospitals Pharmacies

        10.3.2.  Retail Pharmacies

        10.3.3. Drug Stores

        10.3.4. E-Commerce

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis 

        10.5.1. By Product 

        10.5.2. By Distribution Channel 

        10.5.3. By Country/Sub-region

11. Asia Pacific Periodontal Therapeutics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2027

        11.2.1. Systemic Antibiotics

            11.2.1.1. Doxycycline

            11.2.1.2. Minocycline

            11.2.1.3. Metronidazole

            11.2.1.4. Others

        11.2.2. Local Antibiotics

            11.2.2.1. Arestin

            11.2.2.2. Periochip

            11.2.2.3. Atridox

            11.2.2.4. Others

    11.3. Market Value Forecast, by Distribution Channel, 2017–2027

        11.3.1. Hospitals Pharmacies

        11.3.2.  Retail Pharmacies

        11.3.3. Drug Stores

        11.3.4. E-Commerce

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis 

        11.5.1. By Product 

        11.5.2. By Distribution Channel 

        11.5.3. By Country/Sub-region

12. Latin America Periodontal Therapeutics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2027

        12.2.1. Systemic Antibiotics

            12.2.1.1. Doxycycline

            12.2.1.2. Minocycline

            12.2.1.3. Metronidazole

            12.2.1.4. Others

        12.2.2. Local Antibiotics

            12.2.2.1. Arestin

            12.2.2.2. Periochip

            12.2.2.3. Atridox

            12.2.2.4. Others

    12.3. Market Value Forecast, by Distribution Channel, 2017–2027

        12.3.1. Hospitals Pharmacies

        12.3.2.  Retail Pharmacies

        12.3.3. Drug Stores

        12.3.4. E-Commerce

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis 

        12.5.1. By Product 

        12.5.2. By Distribution Channel 

        12.5.3. By Country/Sub-region

13. Middle East & Africa Periodontal Therapeutics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2027

        13.2.1. Systemic Antibiotics

            13.2.1.1. Doxycycline

            13.2.1.2. Minocycline

            13.2.1.3. Metronidazole

            13.2.1.4. Others

        13.2.2. Local Antibiotics

            13.2.2.1. Arestin

            13.2.2.2. Periochip

            13.2.2.3. Atridox

            13.2.2.4. Others

    13.3. Market Value Forecast, by Distribution Channel, 2017–2027

        13.3.1. Hospitals Pharmacies

        13.3.2.  Retail Pharmacies

        13.3.3. Drug Stores

        13.3.4. E-Commerce

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis 

        13.5.1. By Product 

        13.5.2. By Distribution Channel 

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (By Tier and Size of companies)

    14.2. Market Share/Position Analysis, by Company, 2018

    14.3. Company Profiles

        14.3.1. 3M Company

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Growth Strategies

            14.3.1.3. SWOT Analysis

        14.3.2. Den-Mat Holdings, LLC 

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Growth Strategies

            14.3.2.3. SWOT Analysis

        14.3.3. Dexcel Pharma

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Growth Strategies

            14.3.3.3. SWOT Analysis

        14.3.4. Kaken Pharmaceutical Co., Ltd.

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Growth Strategies

            14.3.4.3. SWOT Analysis

        14.3.5. Oral Science 

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Growth Strategies

            14.3.5.3. SWOT Analysis

        14.3.6. Valeant Pharmaceuticals International, Inc. 

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Growth Strategies

            14.3.6.3. SWOT Analysis

List of Tables

Table 01:Price Competitiveness Between Atridox and Arestin

Table 02:Global Pipeline Analysis – Periodontal Therapeutics Drugs Market

Table 03:Global Periodontal Therapeutics Pipeline Drugs Market Size (US$ Mn) Forecast, 2020–2027

Table 04:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 05:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

Table 06:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

Table 07:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 08:Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 09:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 10:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 11:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

Table 12:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

Table 13:North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 14:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 15:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 16:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

Table 17:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

Table 18:Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 19:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 20:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 21:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

Table 22:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

Table 23:Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 24:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 25:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 26:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

Table 27:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

Table 28:Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 29:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017–2027

Table 30:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2017–2027

Table 31:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2017–2027

Table 32:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2017–2027

Table 33:Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027

List of Figures

Figure 01: Global Market Revenue, By Product Type (US$ Mn), 2017

Figure 02: Global Market Revenue (US$ Mn), 2017

Figure 03: Periodontal Therapeutics Market Share Analysis

Figure 04: Porter’s Analysis

Figure 05: Pipeline Drugs Market Forecast, Research Methodology

Figure 06: Global PerioSept Market Revenue (US$ Mn), 2023–2026

Figure 07: Global Periodontal Therapeutics Market, by Product Type

Figure 08: Global Periodontal Therapeutics Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 09: Global Systemic Antibiotics Market Revenue (US$ Mn) 2017–2027

Figure 10: Global Local Antibiotics Market Revenue (US$ Mn) 2017–2027

Figure 11: Periodontal Therapeutics Market Attractiveness Analysis, by Product Type, 2017

Figure 12: Global Doxycycline Market Revenue (US$ Mn) 2017–2027

Figure 13: Global Minocycline Market Revenue (US$ Mn) 2017–2027

Figure 14: Global Metronidazole Market Revenue (US$ Mn) 2017–2027

Figure 15: Global Others Market Revenue (US$ Mn) 2017–2027

Figure 16: Periodontal Therapeutics Market Attractiveness Analysis, by Systemic Antibiotics, 

Figure 17: Global Arestin Market Revenue (US$ Mn) 2017–2027

Figure 18: Global PerioChip Market Revenue (US$ Mn) 2017–2027

Figure 19: Global Atridox Market Revenue (US$ Mn) 2017–2027

Figure 20: Global Others Market Revenue (US$ Mn) 2017–2027

Figure 21: Periodontal Therapeutics Market Attractiveness Analysis, by Local Antibiotics, 2017

Figure 22: Global Periodontal Therapeutics Market Value Share Analysis, by Distribution 

Figure 23: Global Hospital Pharmacies Market Revenue (US$ Mn) 2017–2027

Figure 24: Global Retail Pharmacies Market Revenue (US$ Mn) 2017–2027

Figure 25: Global Drug Stores Market Revenue (US$ Mn) 2017–2027

Figure 26: Global E-Commerce Market Revenue (US$ Mn) 2017–2027

Figure 27: Periodontal Therapeutics Market Attractiveness Analysis, by Distribution Channel, 

Figure 28: Global Periodontal Therapeutics Market Value Share Analysis, by Region, 2017 and 2027

Figure 29: Periodontal Therapeutics Market Attractiveness Analysis, by Region, 2017

Figure 30: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

Figure 31: North America Market Attractiveness Analysis, by Country, 2017

Figure 32: North America Market Value Share Analysis, by Country, 2018 and 2027

Figure 33: North America Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 34: North America Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 35: North America Market Attractiveness Analysis, by Product Type, 2017

Figure 36: North America Market Attractiveness Analysis, by Distribution Channel Type, 2017

Figure 37: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

Figure 38: Europe Market Attractiveness Analysis, by Country, 2017

Figure 39: Europe Market Value Share Analysis, by Country, 2018 and 2027

Figure 40: Europe Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 41: Europe Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 42: Europe Market Attractiveness Analysis, by Product Type, 2017

Figure 43: Europe Market Attractiveness Analysis, by Distribution Channel Type, 2017

Figure 44: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

Figure 45: Asia Pacific Market Attractiveness Analysis, by Country, 2017

Figure 46: Asia Pacific Market Value Share Analysis, by Country, 2018 and 2027

Figure 47: Asia Pacific Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 48: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 49: Asia Pacific Market Attractiveness Analysis, by Product Type, 2017

Figure 50: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2017

Figure 51: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

Figure 52: Latin America Market Attractiveness Analysis, by Country, 2017

Figure 53: Latin America Market Value Share Analysis, by Country, 2018 and 2027

Figure 54: Latin America Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 55: Latin America Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 56: Latin America Market Attractiveness Analysis, by Product Type, 2017

Figure 57: Latin America Market Attractiveness Analysis, by Distribution Channel, 2017

Figure 58: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, 2017–2027

Figure 59: Middle East & Africa Market Attractiveness Analysis, by Country, 2017

Figure 60: Middle East & Africa Market Value Share Analysis, by Country, 2018 and 2027

Figure 61: Middle East & Africa Market Value Share Analysis, by Product Type, 2018 and 2027

Figure 62: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2018 and 2027

Figure 63: Middle East & Africa Market Attractiveness Analysis, by Product Type, 2017

Figure 64: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2017

Figure 65: Global Periodontal Therapeutics Market Share Analysis By Company (2017)

Copyright © Transparency Market Research, Inc. All Rights reserved

Periodontal Therapeutics Market

Schedule a Call